Andrew, Global Quality Assurance and Manufacturing Science & Technology trainee
The STEP program has really heightened my perspective towards different working dynamics in a corporate company, and broadened my understanding of ethos in diverse cultures. Having come directly from academia, I’ve appreciated being part of such a proactive, team-focused working environment. The program has given me a coherent overview to different pharma-industry functions, and the confidence to operate and communicate at a managerial level.
It was really satisfying to know that my work would have such a wide-reaching impact.
Right now, as part of the Manufacturing Science & Technology (MS&T) group at Kundl, Austria, I am working on two projects aiming at redefining pharmaceutical practices. We’re looking to replace classical process validation with continuous process verification. The second project is a global strategic initiative on reducing recurrent and human error deviations across all of our sites. Both projects are geared to replace traditional processes and establish superior compliance to strong health standards. They will also ensure our promise on delivering affordable and high quality medicines is consistently executed on time, every time.
During my first rotation in the Global Quality Incidents group in Holzkirchen, Germany, I worked on quality incidents case management. This meant liaising with different stakeholders across the globe. The focus was on making sure that patients never face any risk from taking Sandoz(or Novartis) medicines. It was really satisfying to know that my work would have such a wide-reaching impact, leaving me with excitement as I look forward onto upcoming challenges, and learning experiences in my last rotation at Broomfield, Colorado, USA.